Microbial α-Hydromuconic Acid Production via Metabolic Pathway

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is no effective method for producing α-hydromuconic acid using a metabolic pathway in microorganisms, as previous attempts lacked direct evidence and were hindered by the unknown nature of the enzyme 3-hydroxyadipate dehydratase, and reported productivity was very low.

Innovation Solution

Identifying and culturing specific microorganisms such as Escherichia, Pseudomonas, Bacillus, and others that naturally produce α-hydromuconic acid, using a medium with suitable carbon sources and inducers like ferulic acid to activate the metabolic pathway for efficient production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If 3-hydroxyadipic acid is dehydrated by enzymatic reaction using 3-hydroxyadipate dehydratase, then α-hydromuconic acid can be produced, but the enzyme is not well known and no direct evidence for the dehydration reaction has been found

Engineering Contradiction:
Improveproduction methodVSAvoidenzyme activity confirmation
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent uses 3-hydroxyadipic acid as an intermediary substance to establish the metabolic pathway. By demonstrating that 3-hydroxyadipic acid is produced from succinic and acetyl CoA, and then dehydrated to form α-hydromuconic acid, the patent provides indirect evidence for enzyme activity without requiring direct detection of the dehydratase enzyme itself.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent performs preliminary identification of the metabolic pathway components before attempting to produce α-hydromuconic acid. By first establishing that 3-hydroxyadipic acid accumulates as an intermediate and can be converted to the target product, the patent creates a reliable foundation for subsequent production efforts.

Inventive Principle:
Principle #10Preliminary action

2Adaptability or versatility

If a non-naturally occurring microorganism is used to produce α-hydromuconic acid through metabolic pathway, then production is theoretically possible, but no direct evidence confirms actual production capability

Engineering Contradiction:
Improvemicroorganism selectionVSAvoidproduction capability confirmation
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent uses 3-hydroxyadipic acid as a marker intermediate to confirm that the metabolic pathway is functional in the microorganism. By detecting the presence and conversion of this intermediary compound, the patent provides reliable evidence that α-hydromuconic acid production is actually occurring, rather than just theorizing based on pathway reconstruction.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If α-hydromuconic acid is produced by naturally occurring microorganism degradation of adipic acid, then production occurs, but productivity is very low at 0.86 mg/L over 17 days

Engineering Contradiction:
Improveproduction rateVSAvoidproduction time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

Instead of allowing microorganisms to degrade adipic acid to produce α-hydromuconic acid (the natural but slow pathway), the patent inverts the approach by having microorganisms synthesize α-hydromuconic acid through a constructed metabolic pathway using succinic and acetyl CoA as starting materials. This reverses the metabolic flow to achieve much higher productivity.

Inventive Principle:
Principle #13The other way round (Inversion)

Solution Approach 2:

The patent performs preliminary engineering of the metabolic pathway by introducing or overexpressing specific enzymes (such as 3-hydroxyadipate dehydratase) before production. This preparatory action ensures that when substrate is provided, the pathway is already optimized for rapid conversion, achieving high productivity within 20-48 hours rather than 17 days.

Inventive Principle:
Principle #10Preliminary action

4Ease of manufacture

If metabolic pathway engineering is attempted without confirmed enzyme knowledge, then production method development is hindered, but extensive research time and resources are required

Engineering Contradiction:
Improvemethod developmentVSAvoidresearch time
Core Design Contradiction:
Ease of manufactureVSLoss of time

Solution Approach 1:

The patent uses 3-hydroxyadipic acid as a detectable intermediary that serves as a proxy for confirming pathway functionality. By monitoring this intermediate compound rather than requiring detailed knowledge of each enzyme's properties, the patent accelerates method development while maintaining scientific rigor.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent allows the metabolic pathway to serve itself by using the natural accumulation and conversion of 3-hydroxyadipic acid as an built-in indicator of pathway activity. This self-monitoring approach eliminates the need for extensive external characterization of enzyme activities, reducing research time and resources.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enables the production of α-hydromuconic acid using a metabolic pathway in microorganisms, achieving productivity levels of at least 1.0 mg/L within 20-48 hours, with specific microorganisms like Cupriavidus metallidurans and Pseudomonas putida demonstrating high yields.

Implementation Method 1

a microorganism having a capacity to produce α-hydromuconic acid... culturing at least one type of microorganism having a capacity to produce α-hydromuconic acid

Methodology Applied
Scientific EffectMetabolic pathway: Fermentation

Data Source

PatentUS11124811B2Method for producing α-hydromuconic acid
Publication Date: 2021.09.21 TORAY INDUSTRIES INC

AI summary

A method of producing α-hydromuconic acid using a metabolic pathway of a microorganism is disclosed. The method of producing α-hydromuconic acid includes the step of culturing at least one type of microorganism having a capacity to produce α-hydromuconic acid, selected from the group consisting of microorganisms belonging to the genus Escherichia, microorganisms belonging to the genus Pseudomonas, microorganisms belonging to the genus Hafnia, microorganisms belonging to the genus Bacillus, microorganisms belonging to the genus Cupriavidus, microorganisms belonging to the genus Acinetobacter, microorganisms belonging to the genus Alcaligenes, microorganisms belonging to the genus Delftia, and microorganisms belonging to the genus Shimwellia.